Development Level

Tbio 2 | 10,625
Tchem 1 | 1,890
Tclin 1 | 602

IMPC Term

abnormal coping response 1 | 12

Disease

Cancer 4 | 2,346
psoriasis 3 | 6,685
Adult T-Cell Lymphoma/Leukemia 2 | 30
Allergic hypersensitivity disease 2 | 123
Alopecia areata 2 | 37
Asthma 2 | 349
Celiac disease 2 | 112
Dermatitis 2 | 107
Diarrhea 2 | 155
Exanthem 2 | 39
Hepatitis B 2 | 103
Hypersensitivity reaction type II disease 2 | 235
Melanoma 2 | 261
Multiple Sclerosis 2 | 498
Peripheral Neuropathy 2 | 303
Rheumatoid Arthritis 2 | 1,160
Type 1 diabetes mellitus 2 | 101
Uveitis 2 | 103
diabetes mellitus 2 | 1,663
osteosarcoma 2 | 7,933
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE V 1 | 1
Acquired immunodeficiency syndrome 1 | 164
Addison's disease 1 | 29
Allergic rhinitis 1 | 91
Amnesia 1 | 17
Anemia 1 | 252
Anorexia 1 | 15
Atopic dermatitis 1 | 944
Autistic Disorder 1 | 320
Autoimmune thyroiditis 1 | 24
Bladder Neoplasm 1 | 109
Brain Neoplasms 1 | 23
CELIAC DISEASE, SUSCEPTIBILITY TO, 3 (finding) 1 | 1
Chancroid 1 | 8
Colitis 1 | 46
Collagen disease 1 | 25
Common variable immunodeficiency 1 | 72
DIABETES MELLITUS, INSULIN-DEPENDENT, 12 1 | 1
Dermatitis, Allergic Contact 1 | 66
Diabetes Mellitus, Insulin-Dependent 1 | 76
Encephalitis 1 | 54
Eosinophilia 1 | 65
Glomerulonephritis 1 | 36
Graft-vs-Host Disease 1 | 5
Graves Disease 1 | 17
Graves' disease 1 | 25
HIV Infections 1 | 100
Hashimoto Disease 1 | 2
Heart disease 1 | 279
Hepatitis 1 | 61
Hepatitis C 1 | 90
Herpes simplex 1 | 19
Human immunodeficiency virus infectious disease 1 | 92
Hyperactive behavior 1 | 31
Hypotension 1 | 53
Hypothyroidism 1 | 89
Infectious mononucleosis 1 | 15
Inflammatory bowel disease 1 | 142
Influenza 1 | 142
Kidney Neoplasm 1 | 27
Kidney disease 1 | 396
Leishmaniasis 1 | 49
Leprosy 1 | 77
Leukemia 1 | 88
Leukopenia 1 | 42
Liver Cirrhosis 1 | 101
Liver disease 1 | 219
Liver neoplasms 1 | 109
Lung Neoplasms 1 | 171
Lung disease 1 | 132
Lymphatic system disease 1 | 14
Lymphoma, T-Cell, Cutaneous 1 | 21
Major Depressive Disorder 1 | 106
Malaria 1 | 140
Measles 1 | 20
Metastatic malignant melanoma 1 | 9
Neoplasm Metastasis 1 | 138
Neoplasms, Experimental 1 | 33
Nephrotic Syndrome 1 | 48
Obstructive jaundice 1 | 5
Oral Submucous Fibrosis 1 | 18
Pain 1 | 70
Pelger-Huet Anomaly 1 | 8
Schistosomiasis 1 | 38
Severe Combined Immunodeficiency 1 | 46
Spinal cord disease 1 | 22
T cell deficiency 1 | 7
Tetanus 1 | 66
Thrombocytopenia 1 | 105
Thyroiditis 1 | 25
Thyrotoxicosis 1 | 38
Toxic shock syndrome 1 | 28
Toxoplasmosis 1 | 16
Tropical spastic paraparesis 1 | 17
Vaccinia 1 | 37
Vasculitis 1 | 64
head and neck cancer and chronic obstructive pulmonary disease 1 | 237
sarcoidosis 1 | 358
systemic lupus erythematosus 1 | 156
tuberculosis 1 | 1,557

Tissue

Endocrine System 4 | 18,512
Female tissues 4 | 18,647
Male tissues 4 | 17,969
Nervous System 4 | 18,561
Skin and soft tissues 4 | 18,115
Blood and immune system 3 | 17,995
Cardiovascular System 3 | 17,958
Digestive Tract 3 | 18,473
Respiratory system 3 | 17,484
Urinary Tract 3 | 18,444
Liver and Pancreas 2 | 18,136

Target Family

Non-IDG 3 | 11,971
Enzyme 1 | 4,146

Grant Application

1ZIABC011074-05 4 | 4
3P41RR001209-23S1 157 | 157
5P41RR001209-22 157 | 157
5P41RR001209-23 157 | 157
2P51RR000165-51 139 | 139
5P51RR000163-52 136 | 136
5P51RR000163-51 132 | 132
5P51RR000165-50 130 | 130
2P51RR000163-50 128 | 128
5P51RR000164-48 127 | 127
5P51RR000164-50 125 | 125
5P51RR000164-49 112 | 112
5P51RR000165-49 106 | 106
5P41RR001646-19 103 | 103
5P41RR001646-20 103 | 103
7P51RR000163-41 100 | 100
2P41RR011823-16 99 | 99
5P51RR000163-42 98 | 98
5P51RR000163-43 98 | 98
5P41RR001081-24 94 | 94
5P41RR001646-18 90 | 90
5P41RR015301-09 82 | 82
5P51RR000167-49 78 | 78
5P41RR002250-26 65 | 65
5P51RR000168-40 65 | 65
5P51RR000168-41 65 | 65
5P41RR001646-27 64 | 64
5P51RR000165-40 63 | 63
5M01RR000188-45 60 | 60
3P41RR010888-05S1 59 | 59
5M01RR000030-40 58 | 58
5M01RR000096-39 57 | 57
5P41RR000954-25 57 | 57
5P41RR000954-26 57 | 57
2P41RR000954-33 56 | 56
5P41RR010888-14 56 | 56
5P41RR012408-13 55 | 55
5M01RR000188-46 53 | 53
5P41RR001646-28 52 | 52
5P51RR000167-48 52 | 52
5P51RR000168-49 52 | 52
5P41RR001646-29 51 | 51
2P41RR002250-25 50 | 50
5M01RR000188-47 50 | 50
5P51RR000166-39 47 | 47
5M01RR000043-40 46 | 46
5P51RR000168-50 46 | 46
5P41RR010888-15 45 | 45
5P41RR015301-08 45 | 45
5P41RR004050-13 44 | 44
5M01RR000847-37 43 | 43
5P41RR004050-12 43 | 43
5P51RR000167-50 43 | 43
5P51RR000169-50 43 | 43
5P41RR000954-34 42 | 42
2P41RR004050-21 41 | 41
5P41RR010888-13 41 | 41
5P51RR000168-48 41 | 41
5P51RR000167-40 40 | 40
5P41RR015301-07 39 | 39
5P51RR000164-39 39 | 39
5P51RR000168-39 39 | 39
2P51RR000169-49 38 | 38
5P51RR000169-48 38 | 38
5P41RR004050-23 37 | 37
5P51RR013986-13 37 | 37
3P51RR000167-46S2 36 | 36
5P41RR001008-25 36 | 36
5M01RR000043-49 35 | 35
5P20RR021905-04 35 | 35
5P41RR004050-22 35 | 35
5M01RR000040-40 34 | 34
5P20RR016481-10 34 | 34
5P41RR001315-19 34 | 34
3P60DE013079-01S1 32 | 32
5M01RR000833-26 32 | 32
5P20RR016481-11 32 | 32
5P20RR020152-07 32 | 32
5P41RR000862-38 32 | 32
5P51RR000166-49 32 | 32
5P60DE013079-02 32 | 32
5S06GM008037-29 32 | 32
5S06GM008037-30 32 | 32
5U41RR007707-10 32 | 32
2P20RR016480-09 31 | 31
5M01RR000827-34 31 | 31
5P41RR002250-24 31 | 31
5P41RR005959-22 31 | 31
5P41RR018522-08 31 | 31
3P60DE013079-03S1 30 | 30
5P20RR016457-10 30 | 30
5P41RR000592-40 30 | 30
5P41RR000592-41 30 | 30
5P41RR000862-36 30 | 30
5P41RR007707-17 30 | 30
5P51RR000166-48 30 | 30
5P60DE013079-03 30 | 30
5P60DE013079-04 30 | 30
5U54AI057168-09 30 | 30
5U54AI057168-10 30 | 30
2U54AI057168-06 29 | 29

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Cytotoxic T-lymphocyte protein 4 CTLA4 Tclin Non-IDG -3.46843 3564.0 656
Interleukin-2 IL2 Tchem Non-IDG -4.34342 23652.7 1173
Hepatocyte growth factor-regulated tyrosine kinase substrate HGS Tbio Enzyme -2.83610 704.3 332
Cancer/testis antigen 1 CTAG1A Tbio Non-IDG -2.54078 463.7 233